Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink

BACKGROUND: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are widely prescribed to reduce cholesterol levels. Studies have suggested that statins are associated with reduced risk of liver cancer, but much of the evidence is from regions of the world with high liver cancer inci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Natl Cancer Inst
Autores principales: McGlynn, Katherine A., Hagberg, Katrina, Chen, Jie, Graubard, Barry I., London, W. Thomas, Jick, Susan, Sahasrabuddhe, Vikrant V.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351398/
https://ncbi.nlm.nih.gov/pubmed/25722350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares